Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Buy
1,141
+349
+44% +$72.3K 0.01% 401
2026
Q1
$178K Sell
792
-9
-1% -$2.24K 0.01% 411
2025
Q4
$193K Buy
801
+6
+0.8% +$1.53K 0.01% 399
2025
Q3
$218K Sell
795
-11
-1% -$3K 0.02% 268
2025
Q2
$208K Buy
806
+3
+0.4% +$716 0.02% 270
2025
Q1
$180K Sell
803
-14
-2% -$3.27K 0.02% 277
2024
Q4
$187K Sell
817
-1
-0.1% -$241 0.02% 270
2024
Q3
$198K Sell
818
-5
-0.6% -$1.12K 0.02% 337
2024
Q2
$157K Buy
823
+66
+9% +$13.4K 0.02% 362
2024
Q1
$150K Sell
757
-26
-3% -$4.76K 0.02% 391
2023
Q4
$135K Buy
783
+38
+5% +$5.84K 0.02% 378
2023
Q3
$110K Buy
745
+57
+8% +$10.3K 0.02% 386
2023
Q2
$150K Buy
688
+8
+1% +$1.78K 0.02% 337
2023
Q1
$149K Buy
680
+13
+2% +$2.82K 0.03% 334
2022
Q4
$139K Buy
667
+35
+6% +$7.69K 0.03% 337
2022
Q3
$138K Buy
632
+10
+2% +$2.28K 0.03% 309
2022
Q2
$130K Buy
622
+37
+6% +$7.88K 0.03% 307
2022
Q1
$142K Sell
585
-28
-5% -$6.77K 0.03% 345
2021
Q4
$160K Buy
+613
New +$159K 0.03% 318

Other funds holding RMD

Quent Capital's RMD Position: Q2 2026 in Review

Quent Capital increased its ResMed (RMD) stake by 44% in Q2 2026, buying an estimated $72.3K and bringing the position to 1,141 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #401.

Quent Capital first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Quent Capital held 1,141 shares of ResMed worth $222K as of Q2 2026.
  • Quent Capital bought 349 ResMed shares in Q2 2026, an estimated $72.3K.
  • ResMed made up 0.01% of Quent Capital's portfolio in Q2 2026, its #401 holding.
  • Quent Capital first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.